Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 9/20 | 0.58 |
| ▸ | LPL | P06858 | 8/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.37 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.36 |
| ▸ | KDR | P35968 | 1/20 | 0.36 |
| ▸ | P4HB | P07237 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21981984 | 1.00 | LIPG (0.58) | LIPGLPLL3MBTL1DGAT1IRAK4 | |
| SCHEMBL27290917 | 1.00 | LIPG (0.58) | LIPGLPLL3MBTL1DGAT1IRAK4 | |
| SCHEMBL31683826 | 1.00 | LIPG (0.58) | LIPGLPLL3MBTL1DGAT1IRAK4 | |
| SCHEMBL21982167 | 1.00 | LIPG (0.58) | LIPGLPLL3MBTL1DGAT1IRAK4 | |
| SCHEMBL31683814 | 1.00 | LIPG (0.58) | LIPGLPLL3MBTL1DGAT1IRAK4 | |
| SCHEMBL23327987 | 1.00 | LIPG (0.58) | LIPGLPLL3MBTL1DGAT1IRAK4 | |
| SCHEMBL31683822 | 1.00 | LIPG (0.58) | LIPGLPLL3MBTL1DGAT1IRAK4 | |
| SCHEMBL23327876 | 1.00 | LIPG (0.58) | LIPGLPLL3MBTL1DGAT1IRAK4 | |
| SCHEMBL23327838 | 0.99 | LIPG (0.59) | LIPGLPLL3MBTL1DGAT1IRAK4 | |
| SCHEMBL18180905 | 0.99 | LIPG (0.55) | LIPGLPLL3MBTL1DGAT1IRAK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210143337-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE | SK MATERIALS CO., LTD. (KR) | 2021-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210143337-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE | L1CAM, EML4, OCIAD2 | LIPG 266/4885LPL 159/4885L3MBTL1 712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.